fashion -WSS

fashion

author：entertainment 2025-09-27 16:49:01 - browse：9469

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： The Readout: Lenmeldy, GLP

focus

WSS

Study says nonprofit hospitals fall short in charity care spending

Judge denies Trump's request for new trial in E. Jean Carroll case

There’s a way to spot data fakery. All journals should be using it

Abortion pill case raises question: who can sue the FDA?

Why the world’s most expensive drug might be worth the price

Delta passengers in Vegas fall sick while waiting on flight in triple

hotspot

fashion

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Roche subsidiary Foundation Medicine opens new headquarters

Malaria cases in Florida and Texas: Here’s what you need to know

Scientists grapple with ethics of stem cell research

Medicare details structure of new drug price negotiation program

There's no autism epidemic. It's an autism diagnosis epidemic

Novavax promises a turnaround & Lilly roils the obesity market

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Bright Health sells Medicare Advantage business to Molina

Patient advocates debate FDA's accelerated approval process

knowledge

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Covid vaccine financial winners and losers, from Pfizer to Novavax

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Hormonal contraceptives don’t actually treat endometriosis

Sanders wants to replace patents with prizes for drug inventions

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

focus

hotspot

focus

focus